Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,690 | -40,859 | -8,650 | -6,708 | -20,373 |
| Depreciation Amortization | 843 | 1,054 | 1,110 | 4,127 | 1,027 |
| Accounts receivable | 111 | -77 | -127 | 81 | 296 |
| Other Working Capital | 891 | -2,687 | 1,329 | -1,731 | 2,992 |
| Other Operating Activity | 7,164 | 25,576 | 526 | -4,429 | 3,506 |
| Operating Cash Flow | $-13,681 | $-16,993 | $-5,812 | $-8,660 | $-12,552 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -617 | -485 | -60 | -28 | -17 |
| Net Acquisitions | N/A | 30,163 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | 17 | N/A | N/A |
| Other Investing Activity | 3,880 | -59 | 17 | 9,119 | 1,101 |
| Investing Cash Flow | $3,263 | $29,619 | $-43 | $9,091 | $1,084 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 266 | 5,514 | 5,060 | N/A | 2,500 |
| Debt Repayment | -191 | -119 | -76 | -1,095 | -43 |
| Common Stock Issued | -188 | 41 | 98 | 5,412 | N/A |
| Other Financing Activity | -36 | 1,754 | 1,250 | -1,012 | -310 |
| Financing Cash Flow | $-149 | $7,190 | $6,332 | $3,305 | $2,147 |
| Exchange Rate Effect | N/A | N/A | N/A | -17 | -59 |
| Beginning Cash Position | 20,608 | 792 | 315 | 511 | 9,891 |
| End Cash Position | 10,041 | 20,608 | 792 | 4,230 | 511 |
| Net Cash Flow | $-10,567 | $19,816 | $477 | $3,719 | $-9,380 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,681 | -16,993 | -5,812 | -8,660 | -12,552 |
| Capital Expenditure | -617 | -535 | -60 | -28 | -17 |
| Free Cash Flow | -14,298 | -17,528 | -5,872 | -8,688 | -12,569 |